跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVODOPA/CARBIDOPA/ENTACAPONA ABDI 150 MG/37.5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEVODOPA/CARBIDOPA/ENTACAPONA ABDI 150 MG/37.5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LEVODOPA/CARBIDOPA/ENTACAPONA ABDI 150 MG/37.5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Abdi Farma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 9, 2020
Approval ID
b707b404d21cd746
Company
Abdi Farma Gmbh
Type
Standard
Approval Details
Approval Id
b707b404d21cd746
Drug Cima Aemps Name
LEVODOPA/CARBIDOPA/ENTACAPONA ABDI 150 MG/37.5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85340
Holder Company Name
Abdi Farma Gmbh
Marketing Company Name
Xentenel Pharma Europe S.L.
Authorization Date
2020-08-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150mg/37.5mg/200mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Abdi Farma Gmbh
Active Ingredients
LEVODOPA
150 mg
CARBIDOPA MONOHIDRATO
40,48 mg
ENTACAPONA
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 9, 2020
Approval ID
b707b404d21cd746
Type
Standard
Back to CIMA-AEMPS Approvals